MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
Architects: Cancer & Oncology Companies _Pharmaceuticals & Biotechnology _ Pancreas, Pancreatic
Verastem Oncology, Inc. (NASDAQ:VSTM)*
Finance & Acquisitions: Verastem
Parents
Verastem Oncology, Inc. (NASDAQ:VSTM)*
Children
2010: 2010: Verastem, Inc.: Series A $16M (2010)
2011: Verastem, Rooted at MIT, Raises $32 Million Series B and Adds ATV and Astellas to Slate of Investors (2011)
2012: Verastem raised $55 million in its IPO (2012)
2016: Verastem Inc. (NASDAQ:VSTM) - 45% discount to net cash
Development-stage biopharmaceutical company focused on stem cell oncology therapeutics, closed a $16M Series A financing.
Participants include Longwood Founders Fund, Bessemer Venture Partners, Cardinal Partners and MPM Capital.
Verastem Inc Stock Quote: VSTM Stock News, Quotes, Analysis
Verastem_www.crunchbase.com
Verastem, Inc. (VSTM) Analyst Research
Jumps
*Key People: VeraStem
Organization & Developments: VeraStem